Global AI in Drug Discovery Market by Current Industry Status, Growth Opportunities, Top Key Players, and Forecast till 2028- A Report by Absolute Markets Insights

Global AI in Drug Discovery market was valued at US$ 281 million in 2019 and is expected to reach US$ 1597.02 million by 2028, growing at a CAGR of 35.64% over the forecast period. The rising use of artificial intelligence (AI) systems aimed at reducing the overall cost of drug discovery and impr...

Arctoris opens a laboratory for research and development in Oxford

Arctoris Ltd, a developer of a fully automated drug discovery system, has opened a new global office and state-of-the-art R&D laboratory in Oxford, UK. The facility houses the proprietary technology of the firm and offers accommodation for its growing business and science departments to suppo...

ELRIG Drug Discovery Innovation Prize awarded to ScreenIn3D

At their conference Drug Discovery 2019, which occurred only recently in Liverpool, U.K., AMSBIO’s partner, ScreenIn3D, won the ELRIG Prize for Innovation in Drug Discovery.

ELRIG Drug Discovery has successfully established itself as the greatest United Kingdom-based get-together ...

Significance of Research in Protein Biology in Drug Discovery

Protein biology is a field that is developing at a constant pace and is gaining more and more relevance in areas like immunology and discovery of drugs. In an exclusive interview, the Project Director of Apollo Therapeutics, Doctor Darren Cawkill along with GSK’s (GlaxoSmithKline) Senior sc...

POP1 Drug Discovery Program Advanced by Propanc Biopharma

Propanc Biopharma, Inc., a biopharmaceutical company creating new cancer therapies for patients with recurrent and metastatic cancer, today reported that the POP1 study and drug discovery program has made great progress in the creation of synthetic variants of both proenzymes, trypsinogen, and ch...